Walleye Trading LLC Spring Works Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

  • $46.7 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$36.5 - $52.5 $102,200 - $147,000
2,800 New
2,800 $137,000
Q4 2022

Feb 14, 2023
BUY
$21.73 - $28.72 $269,452 - $356,128
12,400 New
12,400 $322,000
Q2 2022

Aug 08, 2022
SELL
$18.36 - $60.07 $64,260 - $210,245
-3,500 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$48.97 - $65.46 $171,395 - $229,109
3,500 New
3,500 $198,000

Others Institutions Holding SWTX

# of Institutions
238
Shares Held
69.8M
Call Options Held
144K
Put Options Held
257K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.6B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email